Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
ZVRA similar filings
- 19 Jan 22 KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy
- 20 Dec 21 KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program
- 14 Dec 21 Regulation FD Disclosure
- 10 Nov 21 KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
- 19 Oct 21 KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
- 18 Aug 21 KemPharm Appoints Tamara A. Seymour to Board of Directors
- 12 Aug 21 KemPharm Reports Second Quarter 2021 Financial Results
Filing view
External links